Metraipolis › archive › dc_464ade6802c0

Amplification-free cancer diagnosis based on inhibition of Cas12a activity by site-specific 5mC-modified cfDNA — Europe PMC PMID:41404798

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41404798
DOI
10.1093/nar/gkaf1383
License (as archived)
solo-consultazione
Archived
2026-11-08T20:31:41.997Z
SHA-256 of the archived text
5e3a20cdf8ffdfa5a53723afcd31d6c4341ac1033b9f55b2185cc8ee762efbf9
Stable URL of this page
https://metraipolis.com/documento/dc_464ade6802c0

How to cite

Amplification-free cancer diagnosis based on inhibition of Cas12a activity by site-specific 5mC-modified cfDNA — Europe PMC PMID:41404798 — Europe PMC (en), https://europepmc.org/article/MED/41404798 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_464ade6802c0 (Metraipolis archive dc_464ade6802c0, sha256 5e3a20cdf8ffdfa5a53723afcd31d6c4341ac1033b9f55b2185cc8ee762efbf9)
BibTeX
@misc{dc464ade6802c0,
  title = {Amplification-free cancer diagnosis based on inhibition of Cas12a activity by site-specific 5mC-modified cfDNA — Europe PMC PMID:41404798},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41404798},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_464ade6802c0; sha256 5e3a20cdf8ffdfa5a53723afcd31d6c4341ac1033b9f55b2185cc8ee762efbf9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41404798. Agents can read the archived copy with the MCP tool read_document.